This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

John A. Ambrose, MD; Michael Weinrauch, MD

Arch Intern Med. 1996;156(13):1382-1394.

Abstract
Thrombus formation on a fissured or disrupted atherosclerotic plaque is the main pathogenetic mechanism for the acute coronary syndromes of myocardial infarction and unstable angina. Myocardial infarction results from an acute total occlusion of the artery, while unstable angina is secondary in most cases to mural thrombus formation. Thrombus formation has also been implicated in chronic atherosclerotic disease progression and in restenosis following coronary angioplasty. Therapeutic measures to treat thrombus rely on the ability of drugs to either prevent thrombus extension, dissolve its fibrin component, or prevent further platelet aggregation. Other measures rely on the ability of intracoronary techniques to open coronary arteries. The primary prevention of intracoronary thrombus formation is evolving. Measures to stabilize plaques or to reduce hypercoagulability are being tested or have been tested in recent trials.

Arch Intern Med. 1996;156:1382-1394

Author Affiliations
From the Division of Cardiology, Department of Medicine, Mount Sinai Medical Center, New York, NY.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Evaluation of the Effect of a Concurrent Chronic Total Occlusion on Long-Term Mortality and Left Ventricular Function in Patients After Primary Percutaneous Coronary Intervention
Claessen et al.
J Am Coll Cardiol Intv 2009;2:1128-1134.
ABSTRACT | FULL TEXT  

Plaque rupture and intracoronary thrombus in nonculprit vessels: An eyewitness account
Ambrose and D'Agate
J Am Coll Cardiol 2005;45:659-660.
FULL TEXT  

Use of Low-Molecular-Weight Heparins in the Management of Acute Coronary Artery Syndromes and Percutaneous Coronary Intervention
Wong et al.
JAMA 2003;289:331-342.
ABSTRACT | FULL TEXT  

Global Fibrinolytic Capacity Is Decreased in Polycystic Ovary Syndrome, Suggesting a Prothrombotic State
Yildiz et al.
J. Clin. Endocrinol. Metab. 2002;87:3871-3875.
ABSTRACT | FULL TEXT  

Safety and preliminary efficacy of one month glycoprotein IIb/IIIa inhibition with lefradafiban in patients with acute coronary syndromes without ST-elevation A phase II study
Akkerhuis et al.
Eur Heart J 2000;21:2042-2055.
ABSTRACT  

Risk stratification of emergency department patients with acute coronary syndromes using P-Selectin
Hollander et al.
J Am Coll Cardiol 1999;34:95-105.
ABSTRACT | FULL TEXT  

Pravastatin therapy in hyperlipidemia: effects on thrombus formation and the systemic hemostatic profile
Dangas et al.
J Am Coll Cardiol 1999;33:1294-1304.
ABSTRACT | FULL TEXT  

Pathophysiology and clinical significance of atherosclerotic plaque rupture
Gutstein and Fuster
Cardiovasc Res 1999;41:323-333.
ABSTRACT | FULL TEXT  

Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction
Garratt et al.
J Am Coll Cardiol 1999;33:119-124.
ABSTRACT | FULL TEXT  

Are We All Quacks? Doctors allow one to die The Charlatans kill Jean de la Bruere
Ernst
Arch Fam Med 1997;6:389-390.
ABSTRACT